These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 32373210)
1. Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis. Yang LF; Yang F; Zhang FL; Xie YF; Hu ZX; Huang SL; Shao ZM; Li DQ Theranostics; 2020; 10(12):5242-5258. PubMed ID: 32373210 [No Abstract] [Full Text] [Related]
2. STAT5A modulates CDYL2/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1. Chen X; Wang Z; Zhao X; Zhang L; Zhou L; Li X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Tian H; Li H; Yao M; Li J Oncogene; 2022 Apr; 41(17):2492-2504. PubMed ID: 35314791 [TBL] [Abstract][Full Text] [Related]
3. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition. Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783 [TBL] [Abstract][Full Text] [Related]
4. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression. Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959 [TBL] [Abstract][Full Text] [Related]
5. KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer. Teng Y; Guo B; Mu X; Liu S Biomed Pharmacother; 2018 Dec; 108():766-773. PubMed ID: 30248545 [TBL] [Abstract][Full Text] [Related]
6. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis. Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911 [TBL] [Abstract][Full Text] [Related]
7. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer. Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392 [TBL] [Abstract][Full Text] [Related]
8. Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells. Vad-Nielsen J; Jakobsen KR; Daugaard TF; Thomsen R; Brügmann A; Sørensen BS; Nielsen AL BMC Cancer; 2016 Jan; 16():32. PubMed ID: 26791953 [TBL] [Abstract][Full Text] [Related]
9. CDYL2 Epigenetically Regulates MIR124 to Control NF-κB/STAT3-Dependent Breast Cancer Cell Plasticity. Siouda M; Dujardin AD; Barbollat-Boutrand L; Mendoza-Parra MA; Gibert B; Ouzounova M; Bouaoud J; Tonon L; Robert M; Foy JP; Lavergne V; Manie SN; Viari A; Puisieux A; Ichim G; Gronemeyer H; Saintigny P; Mulligan P iScience; 2020 Jun; 23(6):101141. PubMed ID: 32450513 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer. Deng X; Zhao Y; Wu X; Song G Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944 [TBL] [Abstract][Full Text] [Related]
11. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities. Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505 [TBL] [Abstract][Full Text] [Related]
12. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer. Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222 [TBL] [Abstract][Full Text] [Related]
13. p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis. Li SS; Xu LZ; Zhou W; Yao S; Wang CL; Xia JL; Wang HF; Kamran M; Xue XY; Dong L; Wang J; Ding XD; Bella L; Bugeon L; Xu J; Zheng FM; Dallman MJ; Lam EWF; Liu Q Carcinogenesis; 2017 Oct; 38(11):1092-1103. PubMed ID: 28968743 [TBL] [Abstract][Full Text] [Related]
14. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053 [TBL] [Abstract][Full Text] [Related]
15. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2. Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303 [TBL] [Abstract][Full Text] [Related]
16. Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration. Papanastasiou AD; Sirinian C; Kalofonos HP Breast Cancer Res; 2012 Jul; 14(4):R112. PubMed ID: 22824341 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway. Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430 [TBL] [Abstract][Full Text] [Related]
18. Lnc RNA SNHG20 participated in proliferation, invasion, and migration of breast cancer cells via miR-495. Guan YX; Zhang MZ; Chen XZ; Zhang Q; Liu SZ; Zhang YL J Cell Biochem; 2018 Nov; 119(10):7971-7981. PubMed ID: 29236315 [TBL] [Abstract][Full Text] [Related]
19. Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells. Schmucker H; Blanding WM; Mook JM; Wade JF; Park JP; Kwist K; Shah H; Booth BW Cell Oncol (Dordr); 2018 Apr; 41(2):159-168. PubMed ID: 29181633 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HOTAIR promotes invasion of breast cancer cells through chondroitin sulfotransferase CHST15. Liu LC; Wang YL; Lin PL; Zhang X; Cheng WC; Liu SH; Chen CJ; Hung Y; Jan CI; Chang LC; Qi X; Hsieh-Wilson LC; Wang SC Int J Cancer; 2019 Nov; 145(9):2478-2487. PubMed ID: 30963568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]